CRVS · CIK 0001626971 · operating
Corvus Pharmaceuticals, Inc. (CRVS) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.5 billion, Corvus Pharmaceuticals, Inc. is a small-cap company. The stock currently trades at $17.99, up 0.56% today, with a 52-week range of $2.54–$26.95.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.02 | $-1.02 | -82.1% | |
| 2023 | $-0.56 | $-0.56 | +37.1% | |
| 2021 | $-0.89 | $-0.89 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-25 | 0001558370-25-003621 | SEC ↗ |
| 2023-12-31 | 2024-03-19 | 0001558370-24-003567 | SEC ↗ |
| 2022-12-31 | 2023-03-28 | 0001558370-23-004792 | SEC ↗ |
| 2021-12-31 | 2022-03-10 | 0001558370-22-003281 | SEC ↗ |
| 2020-12-31 | 2021-03-25 | 0001558370-21-003462 | SEC ↗ |
| 2019-12-31 | 2020-03-09 | 0001558370-20-002232 | SEC ↗ |
| 2018-12-31 | 2019-03-07 | 0001558370-19-001660 | SEC ↗ |
| 2017-12-31 | 2018-03-01 | 0001047469-18-001209 | SEC ↗ |
| 2016-12-31 | 2017-03-10 | 0001047469-17-001459 | SEC ↗ |